Tag Archives: ideas

Beating The Market With Profit And Beta: An Exercise

Summary Having established that low-beta stocks outperform, I posited that stocks with returns on invested capital much greater than their cost of capital would also outperform. I further posited that a portfolio comprised of the lowest-beta of these stocks would produce further risk-adjusted outperformance. Using the S&P 1500 as my pool of stocks to choose from, I simulated these strategies over the past 5 years. Here’s what I found. Having recently established in a separate article that low-beta stocks can strongly outperform the market, I wanted to see whether other approaches might outperform the market in an independent fashion, or else add to the alpha of a low-beta approach. I decided to look at whether or not companies with “economic moats” might outperform the broader market as well. The idea is certainly appealing. A company capable of sustaining an economic profit over time would probably benefit from what Morningstar typically contends are moat sources : Network effect, Intangible assets, Efficient scale, Cost advantage, and Switching costs. Certainly, a company imbued with these qualities would be expected to outperform the broader market over a full market cycle, and any discount on such a high-quality firm would be expected to dissipate relatively quickly as the market reestablished a premium reflective of these characteristics. This is the rationale behind certain exchange-traded funds like the Market Vectors Wide Moat ETF (NYSEARCA: MOAT ), and to some degree behind value-based methodologies practiced by Warren Buffett and others of his ilk. The problem, unfortunately, is that moatish qualities are difficult to quantify and may fade over time. A rough guess for the presence of an economic moat for a given firm has been posited by some as the firm being able to post a return on invested capital greater than its weighted average cost of capital, though certainly any given firm in a cyclical industry might be able to do so unreliably. What is probably more predictive is a demonstrated, sustained ability of a firm to generate an economic profit. These might be more readily found in stable industries with predictable dynamics. I posited that a strategy focused on firms with demonstrated sustained economic profits with business models suggestive of stable dynamics would outperform the broader market, and that this strategy would be also prove superior to a low-beta strategy alone. Experimental Method: I gathered 10-year financial data from Morningstar on each of the 1,500 components of the S&P 1500, as well as 10-year price data. I calculated yearly returns on invested capital for each company, and, starting with 2009, calculated a rolling 5-year average ROIC for each company between 2009 to the present. Beta was calculated in rolling 5-year increments using the S&P 500 (NYSEARCA: SPY ) as a benchmark, and a 5-year rolling cost of equity was calculated with the risk-free rate being a rolling average of 10-year treasury interest rates. Weighted average cost of capital was calculated using the normal method, with the cost of debt informally assumed to be either the yearly interest payment over the sum of short and long-term debt versus the interest rate suggested by the company’s interest coverage, whichever was higher. Economic profit was calculated as EVA = ROIC – WACC. From these metrics, the following strategies were simulated: A low-beta strategy, with monthly rebalancing into an equal-weighted portfolio of 12 stocks. On a monthly basis, the entire portfolio would be redistributed into the 12 stocks with the lowest rolling beta values, regardless of valuation. An economic-profit strategy, with monthly rebalancing into an equal-weighted portfolio of 12 stocks. Pre-screens for yearly profitability (e.g., positive yearly EPS) in addition to a positive 5-year rolling EVA were applied. On a monthly basis, the entire portfolio would be redistributed into the 12 stocks with the lowest price to economic-profit ratio (hereafter, “PEVA”). A combined strategy, wherein the top 50 stocks with the lowest PEVA ratios were selected (using the aforementioned pre-screens), and, from these, the 12 with the lowest beta scores would be selected and equal-weighted on a monthly basis; this strategy was repeated using a quarterly rebalancing rule. These 3 strategies were then compared to the S&P 500 and S&P 1500, looking prospectively over the past 5 years. Results: (click to enlarge) As noted previously, a low-beta strategy generated significantly higher annualized returns than the broader market, by a significant amount (26.6% CAGR over the past 5 years versus 15.4% for the SPY and 18.4% for the S&P 1500): (click to enlarge) In comparison, a strategy focused purely on PEVA generated significantly higher returns than even the beta strategy, with a CAGR of 32.76%. (click to enlarge) Returns using a monthly rebalancing rule using a combination of PEVA and beta outperformed a lone beta strategy by nearly 1000 basis points, with a CAGR of 35.3% yearly. (click to enlarge) On a risk-adjusted basis, using a long-term risk-free rate assumption of 4.5%, the PEVA-beta strategy outperformed all other strategies, with a Sharpe ratio of 1.77 (versus 1.64 for low-beta alone). (click to enlarge) Overall, a combined PEVA-low beta strategy offered the strongest risk-adjusted returns over the past five years, and produced the strongest absolute annualized returns over the past 5 years with reasonable compensation for overall risk. Discussion: The results of this exercise suggest that a low-beta strategy may be enhanced by pre-selecting only those firms demonstrating the ability to generate sustained economic profits over time. The success of the PEVA strategy also suggests an underlying valuation component as well, as the strategy focused only on those stocks which had the highest economic profit yield relative to the price. It is worth noting that this strategy did not focus on a single year’s worth of data but rolling 5-year averages; additional study might consider looking at longer rolling averages of ROIC to see if this would affect returns. The astute reader will undoubtedly point out a significant limitation of this study is the relatively low volatility of the overall market during this timeframe, during which time there was virtually no period in which a yearly loss might be recorded. This obviously affects the relative performance of the low-beta or PEVA-beta strategies, though one would probably expect that, if anything, these strategies would be expected to outperform in bear markets. Finally, despite the encouraging results, the PEVA-beta strategy clearly has limitations. Changing the rebalancing period to quarterly shaves off nearly 1000 basis points worth of outperformance and puts the PEVA-beta strategy about on par with the beta strategy alone, reducing the Sharpe ratio to a pedestrian 1.17. Given that an ostensible goal of a focus on sustained economic profits would be to focus on companies capable of outperforming over years at a time, why quarterly rebalancing would diminish returns relative to monthly rebalancing remains a bit unclear. Conclusion: Though generating strong economic profits over time is not necessarily indicative of a stable, high-quality firm, doing so certainly can be suggestive. The success of the PEVA-Beta strategy in this study suggests that focusing on such firms may produce significant outperformance. Though monthly rebalancing costs might be substantial (and capital gains tax burdensome), such a strategy may be worth considering in sideways or downward markets where uncertainty reigns and volatility is high. Current stocks suggested by the PEVA-beta strategy include Coca-Cola (NYSE: KO ), Monster Beverage Corporation (NASDAQ: MNST ), the Brown-Forman Corporation (NYSE: BF.B ) and The Hershey Company (NYSE: HSY ). Other consumer defensive firms make the list, like Altria (NYSE: MO ); trucking firms Knight Transportation (NYSE: KNX ) and Landstar (NASDAQ: LSTR ) are also included.

Does The Rebalanced Barron 400 ETF Look Smarter?

The smart beta Barron’s 400 ETF (NYSEARCA: BFOR ) has made strategic shifts in its portfolio as part of the most recent semi-annual index rebalancing. The fund now seems to have superior fundamental attributes and be less susceptible to the current market turmoil due to increased weighting to the small cap stocks. Background of BFOR The ETF seeks to track the performance of the rules-based and fundamentals-driven Barron’s 400 Index. The benchmark uses the MarketGrader’s equity rating system to select America’s highest-performing stocks based on the strength of their financial statements and the attractiveness of their share prices. Notably, MarketGrader’s methodology assigns grades on a scale of 0-100 based on a proprietary combination of 24 fundamental indicators across growth, value, profitability and cash flow while it screens for size and sector diversification and liquidity. This approach has made BFOR superior to many other ETFs in the space with attractive fundamentals and growth prospects. The fund has been consistently crushing the ultra-popular broad market funds – the SPDR S&P 500 Trust ETF (NYSEARCA: SPY ) and the SPDR Dow Jones Industrial Average ETF (NYSEARCA: DIA ) – by wide margins. The fund gained nearly 23.3% since its June 2013 debut compared to gains of 20% for SPY and 8.9% for DIA. From the year-to-date look, the ETF is down 3.8%, which is better than the decline of 5.8% for SPY and 8.6% for DIA. Despite the strong performance, the product has not been able to garner enough investor interest as depicted by its AUM of $196.1 million. One of the main reasons for the unpopularity might be its expense ratio of 0.65%, which is one of the highest in the multi-cap ETF space. Further, it has a hidden cost in the form of wide bid/ask spread that increases the total cost of trading as it trades in a light volume of about 18,000 shares a day on average. Index Change and New Holdings During rebalancing of the index, sector allocation to the most beaten down energy sector was trimmed by more than half from 9.25% to 4%. Now, financials and industrials remain the top two sectors at 20% each. They are closely followed by consumer discretionary (19.25%), technology (13.75%) and health care (10.25%). In terms of security, 58 companies have found their way to the index and the ETF for the first time ever with the most notable names being GrubHub (NYSE: GRUB ), LendingTree (NASDAQ: TREE ), Blue Nile (NASDAQ: NILE ) and the recently merged Walgreens Boots Alliance (NASDAQ: WBA ). Some other big names that have been added to the holdings list are JPMorgan Chase (NYSE: JPM ), Verizon Communications (NYSE: VZ ), Altria Group (NYSE: MO ) and United Parcel Service (NYSE: UPS ). However, some marquee names such as Microsoft (NASDAQ: MSFT ), Facebook (NASDAQ: FB ), Wal-Mart (NYSE: WMT ), Celgene (NASDAQ: CELG ) and 3M (NYSE: MMM ) were booted from the portfolio. With these changes, the index currently has a total market capitalization of $18.28 billion post-rebalance versus $19.07 billion in March. The drop came on the heels of increased focus toward small cap stocks from 16% to 22%. Exposure to large cap stocks decreased from 27.25% to 25.5% while mid cap stocks saw a decline from 56.25% share to 52.5%. The fund currently holds 401 securities in its basket that are widely spread with nearly 0.25% share each. Bottom Line Though the new holdings suggest a modest change in the fund’s sector exposure, the reallocation to securities saw significant fluctuations in terms of market cap level. This is especially true as the tilt toward small caps suggests that BFOR will now be less exposed to the international markets, currently ruffled by China worries, a strong dollar and global slowdown concerns. As a result, the new portfolio now reflects increasing fundamental attractiveness of companies that earn the lion’s share of their profits in the U.S. The objective of the fund remains the same — offering quality exposure to investors seeking to stay invested in the broad market. The high quality stocks seek safety and protection against volatility in turbulent times and thus, outperform in a crumbling market. Overall, the Barron’s 400 Index and ETF seeks to take advantage of the improving U.S. economy with a heavy tilt toward the cyclical sectors and increased focus on small cap stocks. Link to the original post on Zacks.com

PHB: This Junk Bond Goes Better With REITs Than With The S&P 500

Summary PHB is a junk bond with an emphasis on the 1 to 10 year range. The sector allocation looks pretty good but investors should avoid buying both junk bonds and equity in the consumer discretionary sector. Due to correlation with major indexes, the junk bond ETFs show better correlation benefits with equity REIT funds than with the S&P 500. Investors going heavy on domestic non-REIT equity positions should use longer term treasury securities rather than junk bonds. Investors should be seeking to improve their risk adjusted returns. I’m a big fan of using ETFs to achieve the risk adjusted returns relative to the portfolios that a normal investor can generate for themselves after trading costs. I’m working on building a new portfolio and I’m going to be analyzing several of the ETFs that I am considering for my personal portfolio. One of the funds that I’m considering is the PowerShares Fundamental High Yield Corporate Bond Portfolio ETF (NYSEARCA: PHB ). I’ll be performing a substantial portion of my analysis along the lines of modern portfolio theory, so my goal is to find ways to minimize costs while achieving diversification to reduce my risk level. Expense Ratio The expense ratio is .50%, which is high for a bond fund. That should be a material concern to investors. With yields being relatively low by historic measurements, high expense ratios can quickly create a drag on returns. Credit The credit rating allocations are about what you might expect for a “high yield” bond ETF. Simply put, most of the holdings should be junk bonds and they are. I appreciate that Invesco, the fund sponsor, includes the rating data from both S&P and Moody’s. Maturity The maturity range feels fairly standard for a junk bond ETF. No allocation to bonds longer than 10 years and a heavy focus on the 5 to 10 year range. I’d like to see a yield a little higher than 4.51% for investing in the ETF. The exposure to the 5-10 year range feels a little bit heavy for the yield. I would have expected a heavier portion of the portfolio to be in the 1 to 5 year range. Sector When it comes to the sector allocations, I can’t help but appreciate the way PHB did this. The portfolio structure is extremely diversified when it comes to sectors. The one area that is very notably overweight is the consumer discretionary sector. Because that sector is heavily weighted in the junk bond portfolio, I wouldn’t want to be using an allocation to any ETF that was specifically focused on the consumer discretionary sector. Junk bonds, by definition, are bonds with credit concerns. I wouldn’t want to risk being screwed on equity prices while seeing the bond holdings drop in value because of bankruptcies in the sector. As long as this fund is not combined with a position in the consumer discretionary segment or the energy segment, the fund looks like a nice fit for slipping into a portfolio to increase the yield. The goal here is to improve the income from the portfolio so that investors can live off the income without having to sell off any of the principal. Building the Portfolio The sample portfolio I ran for this assessment is one that came out feeling a bit awkward. I’ve had some requests to include biotechnology ETFs and I decided it would be wise to also include a the related field of health care for a comparison. Since I wanted to create quite a bit of diversification, I put in 9 ETFs plus the S&P 500. The resulting portfolio is one that I think turned out to be too risky for most investors and certainly too risky for older investors. Despite that weakness, I opted to go with highlighting these ETFs in this manner because I think it is useful to show investors what it looks like when the allocations result in a suboptimal allocation. The weightings for each ETF in the portfolio are a simple 10% which results in 20% of the portfolio going to the combined Health Care and Biotechnology sectors. Outside of that we have one spot each for REITs, high yield bonds, TIPS, emerging market consumer staples, domestic consumer staples, foreign large capitalization firms, and long term bonds. The first thing I want to point out about these allocations are that for any older investor, running only 30% in bonds with 10% of that being high yield bonds is putting yourself in a fairly dangerous position. I will be highlighting the individual ETFs, but I would not endorse this portfolio as a whole. The portfolio assumes frequent rebalancing which would be a problem for short term trading outside of tax advantaged accounts unless the investor was going to rebalance by adding to their positions on a regular basis and allocating the majority of the capital towards whichever portions of the portfolio had been underperforming recently. Because a substantial portion of the yield from this portfolio comes from REITs and interest, I would favor this portfolio as a tax exempt strategy even if the investor was frequently rebalancing by adding new capital. The portfolio allocations can be seen below along with the dividend yields from each investment. Name Ticker Portfolio Weight Yield SPDR S&P 500 Trust ETF SPY 10.00% 2.11% Health Care Select Sect SPDR ETF XLV 10.00% 1.40% SPDR Biotech ETF XBI 10.00% 1.54% iShares U.S. Real Estate ETF IYR 10.00% 3.83% PowerShares Fundamental High Yield Corporate Bond Portfolio ETF PHB 10.00% 4.51% FlexShares iBoxx 3-Year Target Duration TIPS Index ETF TDTT 10.00% 0.16% EGShares Emerging Markets Consumer ETF ECON 10.00% 1.34% Fidelity MSCI Consumer Staples Index ETF FSTA 10.00% 2.99% iShares MSCI EAFE ETF EFA 10.00% 2.89% Vanguard Long-Term Bond ETF BLV 10.00% 4.02% Portfolio 100.00% 2.48% The next chart shows the annualized volatility and beta of the portfolio since October of 2013. (click to enlarge) Risk Contribution The risk contribution category demonstrates the amount of the portfolio’s volatility that can be attributed to that position. You can see immediately since this is a simple “equal weight” portfolio that XBI is by far the most risky ETF from the perspective of what it does to the portfolio’s volatility. You can also see that BLV has a negative total risk impact on the portfolio. When you see negative risk contributions in this kind of assessment it generally means that there will be significantly negative correlations with other asset classes in the portfolio. The position in TDTT is also unique for having a risk contribution of almost nothing. Unfortunately, it also provides a weak yield and weak return with little opportunity for that to change unless yields on TIPS improve substantially. If that happened, it would create a significant loss before the position would start generating meaningful levels of income. A quick rundown of the portfolio I put together the following chart that really simplifies the role of each investment: Name Ticker Role in Portfolio SPDR S&P 500 Trust ETF SPY Core of Portfolio Health Care Select Sect SPDR ETF XLV Hedge Risk of Higher Costs SPDR Biotech ETF XBI Increase Expected Return iShares U.S. Real Estate ETF IYR Diversify Domestic Risk PowerShares Fundamental High Yield Corporate Bond Portfolio ETF PHB Strong Yields on Bond Investments FlexShares iBoxx 3-Year Target Duration TIPS Index ETF TDTT Very Low Volatility EGShares Emerging Markets Consumer ETF ECON Enhance Foreign Exposure Fidelity MSCI Consumer Staples Index ETF FSTA Reduce Portfolio Risk iShares MSCI EAFE ETF EFA Enhance Foreign Exposure Vanguard Long-Term Bond ETF BLV Negative Correlation, Strong Yield Correlation The chart below shows the correlation of each ETF with each other ETF in the portfolio. Blue boxes indicate positive correlations and tan box indicate negative correlations. Generally speaking lower levels of correlation are highly desirable and high levels of correlation substantially reduce the benefits from diversification. (click to enlarge) Conclusion This is a solid fund in most aspects. I’d like to see a slightly higher yield for the level of duration risk but that isn’t too bad. The expense ratio could use some work, but it still has some merit in a portfolio. The most interesting thing for investors is that the fund has a fairly high correlation with the S&P 500. When investors are using modern portfolio theory, they may notice that bonds typically have a higher correlation with REITs than with the S&P 500. In this portfolio the REIT exposure is coming from IYR. PHB has a correlation of only .39 with the REITs while posting .60 with the S&P 500, so that should be an interesting factor for investors. Essentially this is suggesting that this kind of junk bond fund makes more sense beside equity REITs than it does with the S&P 500. In short, if investors are using equity REITs as a major source of income, they may want to consider diversifying that position to include one in junk bonds due to the lower correlation of the two investments. Since both investments produce a material amount of current income that is an appealing factor for the dividend growth investor that needs a little more yield. On the other hand, investors that are going very heavy on domestic equity (excluding REITs) would be better served by long term treasury ETFs because the correlation between junk bonds and the S&P 500 is a little too high.